Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-02-24 @ 8:24 AM
Study NCT ID:
NCT02682693
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2016-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Denosumab as an add-on Neoadjuvant Treatment (GeparX)
Sponsor:
GBG Forschungs GmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer Female NOS | View |
| None | Tubular Breast Cancer Stage II | View |
| None | Mucinous Breast Cancer Stage II | View |
| None | Invasive Ductal Breast Cancer | View |
| None | HER2 Positive Breast Cancer | View |
| None | Inflammatory Breast Cancer | View |
| None | Tubular Breast Cancer Stage III | View |
Keywords: